Implementation of a Protocol for ABO-Incompatible Kidney Transplantation – A Three-Center Experience With 60 Consecutive Transplantations

Abstract

The new protocol was easily implemented and there were no graft losses that could be related to ABO-incompatibility. A significant inter-institutional variation in the measurement of anti-AB-antibodies was found, having a substantial impact on the number of immunoadsorptions and consequently on the total cost for the procedure. A standardized fluorescence-activated cell sorting technique for antibody quantification is much needed.